Striatal ensemble plasticity in alcohol use disorder
Striatal ensemble plasticity in alcohol use disorder
批准号:
10734890
负责人:
Jun Wang
金额:
$45.81万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2028-04-30
关键词:
AbstinenceAddressAffectAlcohol consumptionAlcoholsAnatomyAnimalsBehaviorBehavioralBrainChronicClinicalCorpus striatum structureDisinhibitionDopamineExtinctionGlobus PallidusGoalsHabenulaHomosynaptic DepressionHumanKnowledgeLabelLightLong-Term DepressionLong-Term PotentiationMeasuresMediatingMethodologyMolecularNeuronsNormal CellOutputPathologicPathway interactionsPharmaceutical PreparationsPositioning AttributePrefrontal CortexRelapseResearchSelf AdministrationStainsSynapsesSynaptic plasticityTechniquesTestingThalamic structureTherapeuticTimeTissuesTrainingaddictionalcohol abuse therapyalcohol preventionalcohol relapsealcohol seeking behavioralcohol use disorderbrain cellcell typein vivoinnovationneurotransmissionnovelnovel strategiesnovel therapeutic interventionoptogeneticsrecruit
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Relapse is a major clinical challenge in the treatment of alcohol use disorder. Relapse is driven in part
by alcohol-induced synaptic plasticity at the corticostriatal circuit. The dorsomedial striatum (DMS) has been
implicated in alcohol seeking and relapse. The DMS contains direct-pathway medium spiny neurons (dMSNs)
and indirect-pathway MSNs (iMSNs), which positively and negatively regulate alcohol seeking, respectively.
Alcohol-associated behaviors such as operant self-administration activate only a relatively small subset of
neuronal ensembles in the striatum. Although alcohol-induced plasticity is much studied in bulk tissue, it is
unknown whether it is induced in dMSN ensembles. Characterizing synaptic mechanisms of the ensemble
neurons is especially vital to reconcile with the decades of evidence for drug-induced synaptic changes detected
in bulk tissue analysis. In addition, extinction training yields greater suppression of alcohol seeking relative to
abstinence alone, but the mechanism is poorly understood. The absence of alcohol delivery during extinction
likely stimulates thalamic inputs to the DMS and reduces striatal dopamine levels, concurrently inducing
thalamostriatal long-term potentiation (LTP) in DMS iMSNs; this enhances “NoGo” actions, suppressing
alcohol seeking during relapse. LTP in iMSNs is also likely to directly or indirectly suppress dMSN activity by
reducing dopaminergic activity. This application aims to elucidate how extinction training reduces alcohol-
induced corticostriatal plasticity in the DMS ensembles and thereby persistently reduces relapse, with the long-
term objective of determining how such strategies can be used to treat alcohol use disorder. They hypothesize
that alcohol-induced corticostriatal plasticity in dMSN ensembles drives relapse and that extinction training
promotes thalamostriatal plasticity in iMSN ensembles to directly or indirectly, via counteracting dMSN
activity, suppress relapse. Three specific research aims will: 1) test the hypothesis that operant alcohol self-
administration causes long-lasting corticostriatal plasticity in DMS dMSN ensembles, promoting relapse; 2)
test the hypothesis that extinction-mediated thalamostriatal plasticity in DMS iMSN contributes to reduced
relapse to alcohol seeking; and 3) test the hypothesis that extinction training potentiates the inhibitory outputs
from iMSNs to dMSNs or the disinhibitory effects of iMSNs on habenula-projecting globus pallidus neurons,
suppressing relapse. This application is highly innovative because it applies state-of-the-art approaches,
including a combination of ArcTRAP, Cal-Light, and dual-channel optogenetic stimulation, allowing us for the
first time to determine how extinguishing alcohol-evoked synaptic plasticity in specific molecularly defined
neuronal ensembles alters their activities in vivo and thus persistently decreases relapse behavior; these critical
questions cannot be addressed using conventional methodologies. Knowledge generated from this proposal
will provide novel strategies for the long-term treatment of alcohol use disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10457835
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease
-
批准号:10343115
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Repurposing of Maraviroc for the treatment of neuropathic pain
-
批准号:10586296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10364861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
NanoDiagnotic Technology I-Corps Training
-
批准号:10541690
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10543633
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10693823
-
项目类别:
-
资助金额:$73.01万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10653682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10443877
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10191875
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10282122
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of an integrated smartphone/resistive nanosensor for onsite biomonitoring of exposure to pesticides
-
批准号:10255622
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Single-Cell Functional Proteomics Study of Neurodegeneration in Alzheimer's Disease
-
批准号:10191268
-
项目类别:
-
资助金额:$43.86万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10599264
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10513411
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Genetic dissection of Cardiac Conduction System homeostasis and regeneration
-
批准号:9740018
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10190746
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10543627
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10454230
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10693144
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
海外基金